Moxifloxacin
Moxifloxacin is a fluoroquinolone antibiotic used to treat respiratory infections, skin infections, and certain eye infections.
About Moxifloxacin
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic (generic name: Moxifloxacin Hydrochloride) also sold under brand names including Avelox and Vigamox. It is primarily used to community Acquired Pneumonia Acute Bacterial Sinusitis Skin and Soft Tissue Infections Intra abdominal Infections. Moxifloxacin is available in oral tablet (400 mg), iv solution for infusion (400 mg/250 ml premixed), and ophthalmic solution (0.5% — vigamox, moxeza) form. Healthcare providers commonly prescribe Moxifloxacin for conditions including Sinusitis, Chronic Obstructive Pulmonary Disease (COPD), Diabetic Neuropathy, and Osteoarthritis.
Moxifloxacin at a Glance
- Generic name
- Moxifloxacin Hydrochloride
- Brand names
- Avelox, Vigamox
- Drug class
- Fourth-Generation Fluoroquinolone Antibiotic
- Pregnancy category
- FDA Category Category C — Animal studies have shown adverse effects on fetal development at doses higher than human therapeutic doses. There are no adequate well-controlled studies in pregnant women. Fluoroquinolones are generally avoided during pregnancy unless no safer alternative is available because of theoretical concerns about fetal cartilage and joint development.
- Available forms
- Oral tablet (400 mg), IV solution for infusion (400 mg/250 mL premixed), Ophthalmic solution (0.5% — Vigamox, Moxeza)
- Therapeutic categories
- Antibiotic, Fluoroquinolone
- Conditions treated
- 4 related conditions on this site
What Moxifloxacin Is Used For
Dosage Quick Reference
These are general dosage guidelines for Moxifloxacin. Your doctor will determine the appropriate dose for your specific situation.
| Condition | Starting Dose | Maintenance Dose |
|---|---|---|
| Community-acquired pneumonia | 400 mg PO or IV once daily | 400 mg once daily for 7–14 days |
| Acute bacterial sinusitis | 400 mg PO once daily | 400 mg once daily for 10 days |
| Acute exacerbation of chronic bronchitis | 400 mg PO once daily | 400 mg once daily for 5 days |
| Complicated skin and soft tissue infection | 400 mg PO or IV once daily | 400 mg once daily for 7–21 days |
| Complicated intra-abdominal infection | 400 mg IV once daily, then PO | 400 mg once daily for 5–14 days |
| Bacterial conjunctivitis (ophthalmic) | 1 drop in affected eye(s) three times daily | Continue 7 days |
Side Effects
Common Side Effects:
- Nausea and vomiting
- Diarrhea
- Dizziness
- Headache
- Abdominal pain
Serious Side Effects:
- Tendinitis and tendon rupture
- QT prolongation and Torsades de pointes
- Peripheral neuropathy
- CNS effects (seizures, confusion, psychosis)
- Clostridium difficile colitis
- Hepatotoxicity
- Hypersensitivity reactions
See also: Drug Interactions ↓
Drug Interactions
Moxifloxacin has several clinically important interactions, particularly involving QT prolongation and absorption.
- QT-prolonging agents (e.g., amiodarone, sotalol, ondansetron, methadone, antipsychotics, citalopram): Moxifloxacin prolongs the QT interval more than most other fluoroquinolones. Combination significantly raises the risk of torsades de pointes; avoid concurrent use when possible and obtain baseline ECG in higher-risk patients.
- Multivalent cation-containing products (antacids with aluminum, magnesium, calcium; iron; zinc; sucralfate; multivitamins): Form chelation complexes with moxifloxacin that drastically reduce absorption. Take moxifloxacin at least 4 hours before or 8 hours after these products.
- Warfarin: Moxifloxacin can enhance warfarin's anticoagulant effect, raising INR and bleeding risk, partly through gut flora alteration. Monitor INR more frequently during co-administration.
- NSAIDs: Theoretical concern for additive CNS stimulation and seizure risk, particularly in patients with epilepsy. Use cautiously in those with seizure history.
- Corticosteroids: Concurrent systemic corticosteroid use significantly increases the risk of fluoroquinolone-associated tendinitis and tendon rupture, particularly in adults over 60. Counsel patients to report new joint or tendon pain immediately.
- Antidiabetic agents (insulin, sulfonylureas): Fluoroquinolones can cause both hypoglycemia and hyperglycemia. Monitor glucose more closely, particularly in older adults with diabetes.
See also: Questions to Ask Your Doctor ↓
Key Considerations
Known drug interactions
Moxifloxacin has documented interactions with other medications, supplements, and certain foods. Review the Drug Interactions section below and tell your healthcare provider about every medication you take, including over-the-counter products. Jump to section →
Multiple forms available
Moxifloxacin comes in more than one form (Oral tablet (400 mg), IV solution for infusion (400 mg/250 mL premixed), Ophthalmic solution (0.5% — Vigamox, Moxeza)). The right form for you depends on your condition, ease of use, and your provider's recommendation.
Additional Information
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic with broad-spectrum activity against gram-positive, gram-negative, and atypical bacteria. It is commonly used for respiratory tract infections, skin infections, and intra-abdominal infections, offering excellent tissue penetration and once-daily dosing convenience.
Mechanism of Action
Moxifloxacin exerts its bactericidal effects by inhibiting two essential bacterial enzymes:
- DNA gyrase (topoisomerase II): Required for DNA replication, transcription, repair, and recombination
- Topoisomerase IV: Essential for chromosome segregation during bacterial cell division
By inhibiting these enzymes, moxifloxacin prevents bacterial DNA synthesis and leads to cell death. Its 8-methoxy group provides enhanced activity against gram-positive organisms and anaerobes compared to earlier fluoroquinolones, making it particularly effective for respiratory pathogens.
Available Formulations
- Oral tablets: 400 mg film-coated tablets
- IV solution: 400 mg/250 mL for intravenous infusion
- Ophthalmic solution: 0.5% (for bacterial conjunctivitis treatment)
Oral and IV doses are bioequivalent, allowing easy conversion between routes without dose adjustment. This provides flexibility in transitioning hospitalized patients to outpatient oral therapy.
Medical Uses
FDA-Approved Indications:
- Community-acquired pneumonia (CAP) including multidrug-resistant Streptococcus pneumoniae
- Acute bacterial sinusitis
- Acute bacterial exacerbation of chronic bronchitis
- Complicated and uncomplicated skin and skin structure infections
- Complicated intra-abdominal infections (in combination with metronidazole or alone)
- Plague (Yersinia pestis) - prophylaxis and treatment
- Bacterial conjunctivitis (ophthalmic formulation)
Dosing Guidelines
Adults:
- Most infections: 400 mg once daily orally or IV
- Duration: 5-21 days depending on infection type
- Community-acquired pneumonia: 7-14 days
- Acute bacterial sinusitis: 10 days
- Complicated intra-abdominal infections: 5-14 days
- Plague: 10-14 days
No dose adjustment is typically needed for renal or mild-to-moderate hepatic impairment due to balanced elimination.
Important Safety Information
Black Box Warnings:
- Disabling and potentially irreversible adverse reactions affecting tendons, muscles, joints, nerves, and central nervous system
- Exacerbation of myasthenia gravis symptoms
- Reserved for conditions without satisfactory alternative treatment options for certain infections
Contraindications:
- Known hypersensitivity to moxifloxacin or any fluoroquinolone
- Myasthenia gravis (may exacerbate muscle weakness)
Serious Warnings and Precautions:
- QT prolongation: Avoid in patients with known QT prolongation, hypokalemia, or those taking Class IA or III antiarrhythmics
- Tendinitis and tendon rupture risk: Increased with age >60, corticosteroid use, and organ transplantation
- Peripheral neuropathy: Discontinue immediately if symptoms develop
- CNS effects: May cause seizures, increased intracranial pressure, confusion, and toxic psychosis
- Clostridium difficile-associated diarrhea: Monitor for colitis symptoms
- Blood glucose disturbances: Hypoglycemia and hyperglycemia reported
Drug Interactions
- QT-prolonging drugs: Additive arrhythmia risk; avoid concurrent use with antiarrhythmics, antipsychotics, tricyclic antidepressants
- Antacids, iron, zinc, multivitamins: Chelate with moxifloxacin; administer moxifloxacin 4 hours before or 8 hours after
- Warfarin: Enhanced anticoagulant effect; monitor INR closely
- NSAIDs: May increase CNS stimulation and seizure risk
- Corticosteroids: Increased tendon rupture risk; avoid concurrent use when possible
- Sucralfate: Reduces moxifloxacin absorption; separate administration timing
Special Populations
- Renal Impairment: No dose adjustment required for any degree of renal dysfunction
- Hepatic Impairment: Use with caution in moderate-to-severe impairment; limited data available
- Pregnancy: Category C; use only if benefits outweigh potential fetal risks
- Pediatric: Not recommended due to musculoskeletal adverse effects in animal studies
- Elderly: Increased risk of tendon disorders and QT prolongation; monitor carefully
Frequently Asked Questions
Questions to Ask Your Doctor About Moxifloxacin
Consider discussing these topics at your next appointment:
- Is there a non-fluoroquinolone antibiotic that could treat my infection effectively?
- Given my age and other medications, how high is my risk for tendon or nerve side effects?
- Are any of my current prescriptions or supplements going to interact with moxifloxacin?
- What signs should make me stop moxifloxacin and call you immediately?
- How will we know the infection is responding, and when should I follow up?
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.